rs575246362
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_ModerateBP6BP7
The NM_016169.4(SUFU):c.1005C>T(p.Leu335Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016169.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- medulloblastomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
 - nevoid basal cell carcinoma syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina, Genomics England PanelApp
 - basal cell nevus syndrome 2Inheritance: AD Classification: STRONG Submitted by: G2P
 - ocular motor apraxia, Cogan typeInheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
 - Joubert syndrome 32Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
 - Joubert syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
 - apraxiaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 - ciliopathyInheritance: AR Classification: LIMITED Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SUFU | ENST00000369902.8  | c.1005C>T | p.Leu335Leu | synonymous_variant | Exon 8 of 12 | 1 | NM_016169.4 | ENSP00000358918.4 | ||
| SUFU | ENST00000423559.2  | c.1005C>T | p.Leu335Leu | synonymous_variant | Exon 8 of 10 | 1 | ENSP00000411597.2 | |||
| SUFU | ENST00000369899.6  | c.1005C>T | p.Leu335Leu | synonymous_variant | Exon 8 of 11 | 1 | ENSP00000358915.2 | |||
| SUFU | ENST00000471000.1  | n.787C>T | non_coding_transcript_exon_variant | Exon 6 of 6 | 5 | 
Frequencies
GnomAD3 genomes   AF:  0.00000657  AC: 1AN: 152194Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000159  AC: 4AN: 251274 AF XY:  0.0000147   show subpopulations 
GnomAD4 exome  AF:  0.0000239  AC: 35AN: 1461814Hom.:  0  Cov.: 31 AF XY:  0.0000234  AC XY: 17AN XY: 727204 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.00000657  AC: 1AN: 152194Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74332 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
The SUFU c.1005C>T (p.Leu335=) synonymous variant has not been reported in individuals with SUFU-related conditions in the published literature. The frequency of this variant in the general population, 0.000026 (3/113592 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant does not affect SUFU mRNA splicing. Based on the available information, we are unable to determine the clinical significance of this variant. -
Gorlin syndrome;C0025149:Medulloblastoma    Benign:1 
- -
Hereditary cancer-predisposing syndrome    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at